NCT01978262View on ClinicalTrials.gov

Immune and Hormone Response to Influenza Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

Seasonal Inactivated Influenza Vaccine

Quadrivalent seasonal inactivated influenza vaccine, 0.5 mL intramuscularly

Trial Locations (1)

21205

Center for Immunization Research; Johns Hopkins Bloomberg School of Public Health, Baltimore

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT01978262 - Immune and Hormone Response to Influenza Vaccine | Biotech Hunter | Biotech Hunter